Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma?

Research output: Contribution to journalArticlepeer-review

Abstract

Bone marrow transplantation is an increasingly. widely applied treatment for patients with non-Hodgkin's lymphoma and Hodgkin's disease1. It is estimated that approximately 3,000-4,000 autologous transplants will be performed worldwide in 1991. The disease most frequently treated will be non-Hodgkin's lymphoma.

Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalLeukemia and Lymphoma
Volume7
Issue numberS1
DOIs
StatePublished - 1992

Keywords

  • Bone marrow transplantation
  • Non-Hodgkin's lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma?'. Together they form a unique fingerprint.

Cite this